Scientists have created a vaccine for experimental use that protects animals from both seasonal and pandemic variants of the influenza virus. Clinical trials of the vaccine are now under development. Next-generation vaccinations for the flu have the potential to replace seasonal choices if they are shown to be safe and effective at protecting against the […]
Nanoflu vaccine protects against seasonal flu Read More »
To order this detailed 800+ page report, please visit this link Key Inclusions An overview of the current market landscape of companies engaged in manufacturing prefilled syringes, providing information on year of establishment, company size, geographical location of the headquarters and manufacturing facilities, type of material used (glass and plastic), number of barrel chambers
Prefilled Syringes Market (5th edition), 2019-2030 Read More »
Prefilled syringes present an attractive packaging option that doubles as an easy-to-use drug delivery device, and a product life cycle management tool. Consequently, they have become indispensable within the modern healthcare industry. To order this 800+ page report, which features 800+ figures and 150+ tables, please visit this link The financial opportunity within
Roots Analysis has done a detailed study on Prefilled Syringes, covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 800+ page report, which features 800+ figures and 150+ tables, please visit this link Key Market Insights Presently, around 80 types of prefilled syringes are available in
Despite having been available for more than two decades, the demand for prefilled syringes continues to grow, given the numerous benefits they offer over conventional injectable drug delivery systems Roots Analysis is pleased to announce the publication of its recent study, titled, “Prefilled Syringes Market (5th Edition), 2020-2030.” The report features an extensive
To order this 500+ page report, please visit this link Key Inclusions A detailed assessment of the current market landscape of encapsulated cell therapies and affiliated technologies, highlighting various target disease indications, phase of development, encapsulation method, type of cells / API, and route of administration, along with information on various stakeholder companies that are
Encapsulated Cell Therapies and Encapsulation Technologies Market Read More »
Extensive research on cell encapsulation strategies has enabled the development of a variety of technologies capable of immobilizing / enclosing therapeutic entities within biocompatible matrices / carriers. Such products offer a myriad of advantages, and have demonstrated the capability to address existing challenges related to cell therapies and certain other types of interventions as well.
Roots Analysis has done a detailed study on Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 500+ page report, which features 170+ figures and 395+ tables, please visit this link Key Market Insights Presently, over 45 encapsulated
To order this detailed 370+ page report, please visit this link Key Inclusions A detailed analysis of ongoing, biomarker-based clinical trials initiated by big pharmaceutical companies, featuring details on immuno-oncology biomarkers and disease indications being investigated, based on trial registration year, phase of development, recruitment status, therapy design and type of cancer therapy. An analysis
Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030 Read More »
Over time, pharmaceutical players have demonstrated significant interest in this domain and have launched clinical research initiatives to investigate the relevance and applications of these novel biomarkers. Several companies have already developed / are developing analytical tests for novel cancer biomarkers (TMB, MSI / MMR and TILs), intended to assist physicians in making personalized treatment
